Demettre, Edith, Bastide, Lionel, D'Haese, Anne et al. · The Journal of biological chemistry · 2002 · DOI
Researchers found that immune cells from ME/CFS patients show abnormally high breakdown of a protein called RNase L, which normally helps fight viral infections. Instead of remaining whole, this protein is being cut into smaller pieces (37 kDa and 30 kDa fragments), yet these fragments can still work together to fight infections. This abnormal protein breakdown pattern could potentially be used as a marker to help diagnose ME/CFS.
This work provides mechanistic insight into potential immune dysregulation in ME/CFS by identifying abnormal RNase L proteolysis—a protein crucial for antiviral defense. Identifying biomarkers like RNase L fragments could improve diagnosis and help researchers understand whether aberrant protease activity contributes to ME/CFS pathophysiology. Understanding the functional consequences of RNase L truncation may reveal therapeutic targets.
This study does not prove that RNase L proteolysis causes ME/CFS or establish whether this finding is specific to ME/CFS patients versus other conditions. It is a mechanistic description of a biochemical abnormality in cells from CFS patients, but does not demonstrate clinical causation or validate the 37-kDa fragment as a diagnostic tool. The study also does not clarify whether protease elevation is a primary defect or a secondary consequence.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →